433695-36-4 Usage
Uses
Used in Pharmaceutical Industry:
BRL 50481 is used as a PDE7 inhibitor for its acceptable selectivity, making it a valuable compound for in vivo studies. Its ability to induce apoptosis in chronic lymphocytic leukemia cells and increase mineralization in osteoblasts suggests potential applications in the treatment of leukemia and bone-related conditions.
Used in Research and Development:
BRL 50481 is used as a research tool for studying the role of PDE7 in various cellular processes. Its selectivity and potency make it an ideal candidate for investigating the effects of PDE7 inhibition on cell signaling pathways and other biological functions.
Used in Drug Development:
BRL 50481's properties as a PDE7 inhibitor and its effects on apoptosis and mineralization make it a promising starting point for the development of new drugs targeting leukemia, bone disorders, and other related conditions. Its cell permeability also suggests potential for use in drug delivery systems to improve the bioavailability and therapeutic outcomes of PDE7 inhibitors.
Biological Activity
Selective, substrate-competitive inhibitor of phosphodiesterase (PDE) 7 (K i = 180 nM). Displays > 200-fold selectivity over PDE1B, PDE1C, PDE2, PDE3, PDE4A4 and PDE5.
Biochem/physiol Actions
BRL 50481 is a potent and selective PDE7 inhibitor (IC50 = 260 nM).
References
1) Smith et al. (2004), Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages and CD8+ T-lymphocytes; Mol. Pharmacol., 66 1679
2) Zhang et al. (2008), Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia; Proc. Natl. Acad. Sci. USA 105 19532
3) Pekkinen et al. (2008), Effects of phosphodiesterase 7 inhibition by RNA interference on the gene expression and differentiation of human mesenchymal stem cell-derived osteoblasts; Bone 43 84
Check Digit Verification of cas no
The CAS Registry Mumber 433695-36-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,3,6,9 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 433695-36:
(8*4)+(7*3)+(6*3)+(5*6)+(4*9)+(3*5)+(2*3)+(1*6)=164
164 % 10 = 4
So 433695-36-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O4S/c1-7-4-5-8(11(12)13)6-9(7)16(14,15)10(2)3/h4-6H,1-3H3